Speaker: Craig Whiteford MS, PhD Assay Program Director BD Life Sciences Objectives: Join us to learn more about: A microbiome approach to Women’s Health testing. Tackling the concern of CRE and CRE Screening. How the new BD Max™ Assays can help support laboratories today and moving forward. 4:30-5:00 pm Workshop sponsored by Seegene Title: Evaluation of the Allplex Respiratory Panel Assays 1, 2 and 3 for Detection of Respiratory Viruses Speaker: Dr. L. Y. Kong, MD 5:00-6:00 pm Executive Advisory Board Meeting Auditorium Peter Gilgan Research and Learning Centre The Hospital for Sick Children, Toronto ON Tuesday December 4, 2018 8:00-9:00 am Breakfast in the Gallery Defining and Detecting Drug Resistant Tuberculosis: 9:00-9:45 am Navigating an Evolving Landscape Speaker: Dr. Frances Jamieson, MD, FRCPC Medical Microbiologist Medical Lead for the TB and Mycobacteriology Laboratory, Pertussis laboratory, and Laboratory Surveillance at Public Health Ontario, Toronto, ON Objectives: Review the epidemiology of drug-resistant M. tuberculosis (Mtb) in Ontario and Canada (compared to world data), and understand implications for the detection of drug resistant Mtb. Utilize knowledge and understanding of culture-based drug susceptibility testing (DST) and molecular methods for detection of anti-TB drug resistance to improve management of TB patients.
Speaker: Craig Whiteford MS, PhD Assay Program Director BD Life Sciences Objectives: Join us to learn more about: A microbiome approach to Women’s Health testing. Tackling the concern of CRE and CRE Screening. How the new BD Max™ Assays can help support laboratories today and moving forward. 4:30-5:00 pm Workshop sponsored by Seegene Title: Evaluation of the Allplex Respiratory Panel Assays 1, 2 and 3 for Detection of Respiratory Viruses Speaker: Dr. L. Y. Kong, MD 5:00-6:00 pm Executive Advisory Board Meeting Auditorium Peter Gilgan Research and Learning Centre The Hospital for Sick Children, Toronto ON Tuesday December 4, 2018 8:00-9:00 am Breakfast in the Gallery 9:00-9:45 am Defining and Detecting Drug Resistant Tuberculosis: Navigating an Evolving Landscape Speaker: Dr. Frances Jamieson, MD, FRCPC Medical Microbiologist Medical Lead for the TB and Mycobacteriology Laboratory, Pertussis laboratory, and Laboratory Surveillance at Public Health Ontario, Toronto, ON Objectives: Review the epidemiology of drug-resistant M. tuberculosis (Mtb) in Ontario and Canada (compared to world data), and understand implications for the detection of drug resistant Mtb. Utilize knowledge and understanding of culture-based drug susceptibility testing (DST) and molecular methods for detection of anti-TB drug resistance to improve management of TB patients.
NMG_Final_Program_2018.docx